-
WNT5a/GSK3/β-Catenin Controls FAP Adipogenesis
2026-08-19
This study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By combining pharmacological screening, mass cytometry, network modeling, and transcriptomic datasets, the authors connect impaired WNT5a signaling with pathological muscle fat accumulation and show that GSK3 blockade can preserve a pro-regenerative FAP phenotype.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-08-19
HRP Goat Anti-Mouse IgG (H+L) Antibody supports enzyme-based detection of mouse-derived primary antibodies in Western blotting, ELISA, IHC, and ICC. It should be used only after confirming mouse-primary compatibility and validating dilution, incubation, substrate, and background performance in the intended assay; no directly matched paper evidence for SKU K1221 is assumed.
-
Indometacin Sodium: Translational Assay Design
2026-08-18
Indometacin Sodium is more than a conventional COX inhibitor for inflammation research. This guide develops a translational framework for interpreting prostaglandin, differentiation, and proliferation assays while avoiding disease-mimicry and exposure-related misattribution.
-
Indomethacin: Workflows for Inflammation & Lipid Biology
2026-08-18
Indomethacin is more than a nonsteroidal anti-inflammatory drug: its COX preference, PPAR activity, and membrane effects support layered experiments in inflammation research and lipid biology. This guide converts those properties into practical dose-response, adipocyte, mitochondrial, and membrane-signaling workflows with troubleshooting steps for reproducible results.
-
β-Pseudouridine for RNA Fidelity Workflows
2026-08-17
β-Pseudouridine supports practical RNA modification studies spanning analytical calibration, exogenous nucleoside perturbation, and translational-fidelity assays. This workflow guide also clarifies a critical distinction: the free C-glycoside isomer of uridine is a research reagent and reference standard, not a direct substitute for an activated nucleotide used during in vitro RNA synthesis.
-
Tubastatin A: From HDAC6 Selectivity to Translation
2026-08-17
Tubastatin A is more than a selective HDAC6 inhibitor: it is a mechanistic probe linking protein acetylation, cytoskeletal behavior, inflammatory signaling, and regulated cell death. New porcine cardiac-arrest data sharpen its translational potential while defining the evidence boundaries researchers must respect.
-
Primidone: From Target Biology to ALS Assays
2026-08-16
Primidone (Mysoline) is more than an established antiepileptic drug: its concentration-dependent effects on TRPM3, RIPK1, and hPON1 create distinct research opportunities. This guide converts mechanistic and clinical evidence into practical assay, dosing, and translational decisions.
-
Sulfisomidine: Bench Workflows for Microbes and hPON1
2026-08-15
Sulfisomidine, also known as sulfamethin, connects bacterial folate-pathway research with human serum paraoxonase 1 inhibition studies. This practical guide covers solution preparation, enzyme kinetics, microbial assays, environmental workflows, and troubleshooting for reproducible bench applications.
-
Puromycin Aminonucleoside: Reliable Injury Models
2026-08-14
This scenario-driven guide explains how Puromycin aminonucleoside, SKU A3740, can support controlled podocyte injury, cytotoxicity, and nephrotic disease-modeling workflows. It covers concentration selection, pH-dependent uptake, solubility, storage, data interpretation, and practical vendor evaluation.
-
PNU 74654: Wnt Signaling Workflow Guide
2026-08-14
PNU 74654 provides a DMSO-compatible perturbation tool for testing Wnt/β-catenin control of transcription, cell fate, and proliferation. This workflow separates literature-validated muscle progenitor biology from exploratory applications in cancer research and stem cell research, with practical controls for solubility, dosing, and pathway-specific readouts.
-
Nile Red Workflow for Lipid Droplet Imaging
2026-08-13
Build a dual-channel Nile Red assay that distinguishes lipid droplets from membrane-associated fluorescence while supporting quantitative lipid storage analysis. The workflow translates findings from an oleic acid lipid-accumulation study into practical imaging, control, and troubleshooting decisions.
-
Schizophrenia Risk Loci in Developing Neurons
2026-08-13
Liu et al. show that schizophrenia-associated GWAS loci converge on different molecular pathways in developing cortical interneurons and glutamatergic neurons. Their combination of iPSC-derived neuronal models, regulatory genomics, morphology, and electrophysiology provides a cell-type-specific framework for interpreting schizophrenia risk mechanisms during neurodevelopment.
-
IWP-L6 for Reliable Wnt Pathway Assays
2026-08-12
Learn how IWP-L6, SKU B2305, can help researchers distinguish Wnt pathway effects from nonspecific cytotoxicity in viability, proliferation, developmental, and metabolic assays. This scenario-based guide covers concentration selection, DMSO handling, interpretation, and vendor reliability using product data and recent Wnt literature.
-
Patient-Derived Spheroids in Organ-Confined Prostate Cancer
2026-08-12
Linxweiler and colleagues developed viable three-dimensional spheroid cultures from radical prostatectomy specimens and characterized them as a translational model of organ-confined prostate cancer. The cultures retained key epithelial and prostate cancer markers, could be cryopreserved, and showed differential responses to androgen receptor-directed and cytotoxic drugs, highlighting their value for patient-derived prostate cancer research.
-
Measuring Drug Response Beyond Cell Viability
2026-08-11
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. This framework helps researchers interpret assay timing, separate cytostatic effects from cytotoxicity, and design more informative in vitro studies.